![Michael DIBLASI | Publications Manager | PhD | Boston University, MA | BU | African Studies Center; Archaeology Program | Research profile Michael DIBLASI | Publications Manager | PhD | Boston University, MA | BU | African Studies Center; Archaeology Program | Research profile](https://i1.rgstatic.net/ii/profile.image/272191094784002-1441906822052_Q512/Michael-Diblasi.jpg)
Michael DIBLASI | Publications Manager | PhD | Boston University, MA | BU | African Studies Center; Archaeology Program | Research profile
![Roberta DI BLASI | MD PhD | MD PhD | Hôpital Saint-Louis (Hôpitaux Universitaires Saint-Louis, Laboisière, Fernand-Widal), Paris | Service d'Hémato-Oncologie | Research profile Roberta DI BLASI | MD PhD | MD PhD | Hôpital Saint-Louis (Hôpitaux Universitaires Saint-Louis, Laboisière, Fernand-Widal), Paris | Service d'Hémato-Oncologie | Research profile](https://i1.rgstatic.net/ii/profile.image/596182241918977-1519152331736_Q512/Roberta-Di-Blasi.jpg)
Roberta DI BLASI | MD PhD | MD PhD | Hôpital Saint-Louis (Hôpitaux Universitaires Saint-Louis, Laboisière, Fernand-Widal), Paris | Service d'Hémato-Oncologie | Research profile
![A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma | Nature Medicine A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01969-y/MediaObjects/41591_2022_1969_Fig1_HTML.png)